Table 1.
Patient Characteristics (Median (min, max) or N (%) reported; N=32 patients).
| Summary | |
|---|---|
| Age | 60.5 (36, 81) |
| Sex | |
| Female | 13 (41) |
| Male | 19 (59) |
| Performance status | |
| 0 | 7 (22) |
| 1 | 24 (75) |
| 2 | 1 (3) |
| Primary site | |
| Appendix* | 1 (3) |
| Cecum* | 1 (3) |
| Cervix | 3 (9) |
| Esophagus* | 1 (3) |
| Lung | 6 (19) |
| Prostate | 2 (6) |
| Rectum* | 4 (12) |
| Small intestine* | 6 (19) |
| Stomach* | 2 (6) |
| Thymus gland | 1 (3) |
| Unknown primary | 5 (16) |
| Ethnicity | |
| Hispanic | 2(6) |
| Not hispanic | 30 (94) |
| Race | |
| White | 25 (78) |
| Black | 6 (19) |
| Asian | 1 (3) |
| Grade | |
| High grade | 18 (56) |
| Intermediate grade | 10 (31) |
| Low grade | 4 (12) |
| Prior lines of therapy | 2 (0, 7) |
Asterisks (*) denotes primary sites included in the GI (non-pancreatic) cohort